Quick Answer
CollPlant Biotechnologies Ltd reported Research And Development Expense of $8.19 million for the year ending 2025.
- CollPlant Biotechnologies Ltd showed a decrease of -22.1% in Research And Development Expense from 2024 to 2025.
- This data is from CollPlant Biotechnologies Ltd's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), CollPlant Biotechnologies Ltd's Research And Development Expense has declined by 64.3%.
- Historical annual values: Fiscal year 2025: $8.19 million | Fiscal year 2024: $10.52 million | Fiscal year 2023: $10.48 million | Fiscal year 2022: $10.26 million | Fiscal year 2021: $7.63 million | Fiscal year 2020: $4.07 million | Fiscal year 2019: $4.41 million | Fiscal year 2018: $3.88 million | Fiscal year 2017: $584.0 thousand | Fiscal year 2016: $29.20 million | Fiscal year 2015: $22.92 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: